Our antibody experts are speaking and exhibiting at this year’s Antibody Engineering & Therapeutics USA 2025 Event in San Diego, CA at the Marriott Marquis on Dec. 14- 17th.  Meet with our VP of Research and Innovation, Dr Rob Holgate from our Cambridge, UK site, SVP of Commercial Strategy, Gavin Murdoch, and Sr. Director of Business Development, Kevin Ranke, in booth #401 to discuss your project-specific needs and to get an update on the latest expansion news at Abzena.

Rob will also be presenting a scientific briefing presentation on Dec. 16th, Day 2 of the conference at 12:35pm entitled:  “How Flexible & Robust Mammalian Cell Line Platforms Deliver Clinical Success”

Presentation Summary:
Our fully integrated AbZelectPRO™ platform enables the rapid delivery of stable, high-producing cell lines to support the production of antibodies and more difficult-to-express proteins. The platform combines our AbZelectPRO™ CHO-K1 and AbZelectPRO™-KO GS knockout cell lines together with ProteoNic’s 2G UNic® vector technology and, supported by our comprehensive analytics capabilities, provides a state-of-the-art offering to support our clients as they transition from R&D into preclinical and clinical development.

Schedule a meeting with Gavin, Rob & Kevin at the conference: